Cargando…
Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges
Prostate cancer is a leading cause of death among men in the United States, and currently early diagnosis and appropriate treatment remain key approaches for patient care. Molecularly prostate cancer cells carry multiple perturbations that generate malignant phenotype capable of uncontrolled growth,...
Autores principales: | Dasgupta, Subhamoy, Srinidhi, Srinivasa, Vishwanatha, Jamboor K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307249/ https://www.ncbi.nlm.nih.gov/pubmed/22438770 http://dx.doi.org/10.4103/1477-3163.93001 |
Ejemplares similares
-
MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1
por: Rajendiran, Smrithi, et al.
Publicado: (2014) -
MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression
por: Kpetemey, Marilyne, et al.
Publicado: (2015) -
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
por: Gdowski, Andrew S., et al.
Publicado: (2017) -
Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model
por: Rothermund, Christy A, et al.
Publicado: (2005) -
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
por: Gdowski, Andrew S, et al.
Publicado: (2017)